Tag: Licensing

Browse our exclusive articles!

OpenAI’s ChatGPT: US FTC Examines Risks of Consumer Harm

OpenAI's ChatGPT under FTC investigation - potential harm to consumers & accuracy concerns. Implications for AI industry.

Who owns the AI-generated code? The question of ownership when ChatGPT’s AI is involved in app development.

Discover why determining ownership of AI-generated code is complex and uncertain, and why seeking legal guidance is advised. Learn more here.

Sam Altman Worries Creating ChatGPT Could Have Risked AI’s Potentially Harmful Effects

OpenAI CEO, Sam Altman expresses concerns over the potential dangers of AI chatbot, ChatGPT. Altman emphasizes the need for AI regulation and calls for caution when developing powerful AI systems. Read about his comments and the concerns of other tech leaders in this article.

OpenAI’s ChatGPT Attracts One Billion Monthly Visitors

OpenAI.com, developer of ChatGPT, an AI tool for businesses, experienced a 54% increase in website traffic in March 2023, now nearing one billion visitors per month. As AI becomes integrated across industries, businesses can benefit from its inevitable impact. Despite concerns of plagiarism and ownership, the real estate industry sees promise in ChatGPT, with companies such as Zillow and Redfin signing up. With a rise in interest in AI-powered solutions, OpenAI.com's growth signals a new era.

Regulating AI Technology to Safeguard Consumers and Workers

Regulators are taking action to protect consumers and workers from the rapidly evolving Artificial Intelligence technology. The CFPB, FTC, EEOC, DOJ, and OpenAI are all dedicated to mitigating the risks of this powerful technology. Government and industry collaboration is essential for regulating AI and preventing any negative impact on people.

Popular

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.

Pioneering Research Uncovers Vital Biomarker for Orbital Inflammation

An in-depth study reveals HLF as a potential biomarker for orbital inflammation, offering new insights for diagnosis and treatment strategies.

Subscribe

spot_imgspot_img